Invitation to Incisive Health Morning Club – 4 February

28 January 2021

Invitation to Incisive Health Morning Club

Laying the ground for a better plasma collection in Europe: the need for an appropriate EU policy framework

with Maarten Van Baelen, Plasma Protein Therapeutics Association, Leni von Bonsdorff, International Plasma and Fractionation Association, Dr. Franz Weinauer, Bavarian Red Cross (formerly) and Frank Willersinn, Alpha-1

Thursday, 4 February 2021, 8:30 – 9:30am CET
Virtual meeting
Register here

We are pleased to invite you to the third edition of the Incisive Health Morning Club with Maarten Van Baelen, Executive Director, at the Plasma Protein Therapeutics Association, Leni von Bonsdorff, Executive Director, International Plasma and Fractionation Association, Dr. Franz Weinauer, Former Medical Director, Bavarian Red Cross and Frank Willersinn, Board of Directors, Alpha-1. The discussion will be introduced by Francesca Scassellati Sforzolini, Managing Director of Incisive Health Brussels and moderated by Eduardo Pisani, Strategic Advisor to Incisive Health.

With the European Commission set to revise the EU legislation on blood, tissues and cells in 2021, attention has been drawn to the crucial importance of plasma collection in Europe, especially as it suffered some decline this year due to the ongoing COVID-19 pandemic. Amongst other things, the initiative aims to update the current legislation to allow for more flexible alignment to scientific and technological developments and address increasing commercialisation and globalisation of the sector. In this context, this event will explore the importance of plasma donations in Europe and the need for a more appropriate EU policy framework to be put in place, as more than ever, donations are necessary to meet the growing clinical need for plasma derived medicinal products.

During this Morning Club discussion, Maarten Van Baelen and Leni von Bonsdorff will build on their expertise in the plasma protein therapies field, while Dr. Franz Weinauer and Frank Willersinn will respectively provide a medical and patient perspective on the subject, exploring what the future landscape may hold. The webinar will be divided into three main discussion themes. In each section, Maarten, Leni, Franz and Frank will provide an overview and initial thoughts, before the discussion is opened up to questions.

Register